July Knowledge Translation Update
Coming Soon – Series of Webinars on Knowledge Translation
Knowledge translation (KT) is a dynamic and iterative process that includes dissemination of knowledge to provide more effective health services and products, and to strengthen the health care system [1]. KT products (e.g., leaflets, videos, websites) are important tools to inform health care providers, patients and families about the process of KT, thereby ensuring that they have the confidence and knowledge needed to bring their expertise forward to guide discussions and inform decisions regarding health care, research, and therapy development for Canadians living with Neuromuscular Diseases (NMD).
The NMD4C is excited to announce the launch of a series of webinars that will support KT abilities, with the first webinar to be held on Wednesday, September 29th.
Please stay tuned for more details to come!
Meet our Newest Team Member : Samar Muslemani
We are happy to welcome Ms. Samar Muslemani to the KT team. Samar is an occupational therapist and research student who will support the KT team and act as a knowledge broker for the NMD4C.
Samar will take over her role from Dr. Valérie Gagné; the NMD4C are very appreciative of all the hard work that Dr. Gagné has done for the network over the past year, and we would like to wish her the best in her future pursuits.
[1] https://cihr-irsc.gc.ca/e/29418.html
Read next...
NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.